Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for PKC-active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PKC-active participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 0 | 3 | 0 | 0 | 0 | 0 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
| EGFR_MAPK | 58 | Network | Shared_Object_EGFR_MAPK, MAPK, Ras, EGFR, Sos |
| Model of MAPK activation by EGFR in the synapse. Demonstration programs using this model are available here. Primary citation:Bhalla US. Biophys J. (2004) 87(2):745-53. | |||
PKC-active acting as a Molecule in EGFR_MAPK Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered | |
| PKC-active | EGFR_MAPK Accession No. : 58 | EGFR_MAPK Pathway No. : 229 | 0.09 | 1000 | Yes | |
PKC-active acting as an Enzyme in EGFR_MAPK Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | PKC-active / PKC-act-raf | EGFR_MAPK Accession No. : 58 | EGFR_MAPK Pathway No. : 229 | 66.6667 | 4 | 4 | explicit E-S complex | Substrate craf-1 Product craf-1* |
| Rate consts from Chen et al Biochem 32, 1032 (1993) k3 = k2 = 4 k1 = 9e-5 recalculated gives 1.666e-5, which is not very different. Looks like k3 is rate-limiting in this case: there is a huge amount of craf locked up in the enz complex. Let us assume a 10x higher Km, ie, lower affinity. k1 drops by 10x. Also changed k2 to 4x k3. Lowerd k1 to 1e-6 to balance 10X DAG sensitivity of PKC | ||||||||
| 2 | PKC-active / PKC-inact-GAP | EGFR_MAPK Accession No. : 58 | EGFR_MAPK Pathway No. : 229 | 3.33333 | 4 | 4 | explicit E-S complex | Substrate GAP Product GAP* |
| Rate consts copied from PCK-act-raf This reaction inactivates GAP. The idea is from the Boguski and McCormick review. | ||||||||
| 3 | PKC-active / PKC-act-GEF | EGFR_MAPK Accession No. : 58 | EGFR_MAPK Pathway No. : 229 | 3.33333 | 4 | 4 | explicit E-S complex | Substrate inact-GEF Product GEF* |
| Rate consts from PKC-act-raf. This reaction activates GEF. It can lead to at least 2X stim of ras, and a 2X stim of MAPK over and above that obtained via direct phosph of c-raf. Note that it is a push-pull reaction, and there is also a contribution through the phosphorylation and inactivation of GAPs. The original PKC-act-raf rate consts are too fast. We lower K1 by 10 X | ||||||||
color.